Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesCTPET/CT identifies bone demineralization in breast cancer patientsPET/CT holds promise as an opportunistic osteoporosis screening tool in high-risk oncology subgroups.MRIIs MRI in patients with retained metal fragments dangerous?Womens ImagingAI shows promise as second reader in breast cancer screeningResidents/FellowsRad residents show interest in global health imaging, but face barriersAIInvestigators test ChatGPT-4 Turbo for radiology AI monitoring